Drug Pipeline

Triheptanoin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05933200 A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in… Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Active, Not Recruiting
Phase 2
NCT07097311 Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA… Medium-chain Acyl-CoA Dehydrogenase Deficiency Recruiting
Phase 1
NCT06340685 Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC)… Pyruvate Dehydrogenase Complex Deficiency Recruiting
Sponsors Running Triheptanoin Trials
Ultragenyx Pharmaceutical Inc (1) Jirair Krikor Bedoyan (1) Jerry Vockley, MD, PhD (1)
Get alerts when Triheptanoin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free